epidemiology and risk factors

This very large epidemiological study calculated stroke incidence, prevalence, mortality, disability-adjusted life-years and the population attributable fraction of disability-adjusted life years associated with 19 risk factors, for 204 countries from 1990 to 2019.

The aim of this study was to estimate weather-dependent signatures in the early phase of the pandemic, while controlling for socio-economic factors and non-pharmaceutical interventions.

The objective of this study was to investigate the association between risk of COVID-19 in nonimmune individuals and the number of their family members with known immunity acquired from a previous COVID-19 infection or full vaccination (2 vaccine doses).

In this study, the authors aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020.

In this article the authors reviewed all vaccine related CVT published cases by April 30, 2021.

The aim of this study was to evaluate whether mortality of patients with CVST-VITT has decreased over time.

The objective of this study was to derive and validate risk prediction algorithms to estimate the risk of COVID-19 related mortality and hospital admission in UK adults after one or two doses of COVID-19 vaccination.

This study aimed to identify risk factors for post-vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness.

In this study the authors trialled daily testing of contacts as an alternative to assess whether this resulted in similar control of transmission, while allowing more school attendance.

This critical review highlights the injury pathways possible through SARS-CoV-2 infection that have the potential to increase and contribute to cognitive impairment and dementia.

In this article the authors detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω in 13.6% of 3,595 patients with critical COVID-19, including 21% of 374 patients > 80 years, and 6.5% of 522 patients with severe COVID-19.

Using a cross-sectional questionnaire study, the authors examined the experience of patients with PNES at a single Comprehensive Epilepsy Center in New York City.

In this study the authors identified breakthrough infections by performing extensive evaluations of health care workers who were symptomatic (including mild symptoms) or had known infection exposure.